Showing 601-610 of 3545 results for "".
A Tale of Two Toxins
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-tale-of-two-toxins/22074/From a recent approval to a late-stage candidate, the field is evolving. Experts weigh in on the latest.Flower Power: Inside Growing Interest in Topical Botanicals
https://practicaldermatology.com/topics/practice-management/flower-power-inside-growing-interest-in-topical-botanicals/20524/Botanicals are cropping up in growing numbers of skincare products. Are you ready to field patient questions?8 Ways to Use LinkedIn to Gain Mileage for Your Practice
https://practicaldermatology.com/topics/practice-management/8-ways-to-use-linkedin-to-gain-mileage-for-your-practice/21495/Why Assessing Vitiligo Activity is Critical for Limiting Spread
https://practicaldermatology.com/conferences/maui-derm-2024/why-assessing-vitiligo-activity-is-critical-for-limiting-spread/20248/Chief Medical Editor Neal Bhatia, MD talks with “Mr. Vitiligo Himself,” John E. Harris, MD, PhD about the importance of determining whether vitiligo patients are active or stable in order to “shut off” spreading as soon as possible.One Doctor’s Legal Education Odyssey
https://practicaldermatology.com/topics/practice-management/one-doctors-legal-education-odyssey/23999/What happens when a seasoned dermatologist and dermatopathologist pursues his childhood dream of becoming a lawyer?Open Payments Program: Does it Enhance Open Discussion About Financial Ties Between Dermatologists and Industry?
https://practicaldermatology.com/youngmd-connect/resident-resource-center/open-payments-program-does-it-enhance-open-discussion-about-financial-ties-between-dermatologists-and-industry/23619/The majority of physicians practicing in the United States have received some form of compensation from private industry during their careers. These payments may include consulting fees, compensation for speaking engagements, and stock options. Certain payments take indirect forms, such as physicPhysician Spotlight: Lindsey A. Bordone, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-lindsey-a-bordone-md/23216/Are You Paying Too Much In Taxes?
https://practicaldermatology.com/topics/practice-management/are-you-paying-too-much-in-taxes/23054/How a common tax mistake can cost you thousands.Inflammatory Responses: Managing Psoriasis in Light of Comorbidities
https://practicaldermatology.com/topics/psoriasis/inflammatory-responses-managing-psoriasis-in-light-of-comorbidities/20440/The accumulated evidence suggests that dermatologists must take an active role in addressing risks.Humphries to Valeant, Restylane Line Expands, 2016 Highlights
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-humphries-to-valeant-restylane-line-expands-2016-highlights/18709/The filler market in the US expands with FDA approval of Galderma's Restylane Refyne and Restalyne Define for the treatment of nasolabial folds in patients over the age of 21. The gels are manufactured with XpresHAn Technology, which allows a range of flexibility and support for varied patient needs